Highlights

Good Articles to Share

Author: Tan KW   |   Latest post: Tue, 20 Oct 2020, 5:37 PM

 

Chinese researchers to test double doses of CanSino’s coronavirus vaccine candidate

Author:   |    Publish date:


BEIJING, Sept 18 — Researchers plan to start a clinical trial for an additional dose of a coronavirus vaccine candidate co-developed by China’s CanSino Biologics Inc and a military-backed research unit, clinical trial registry data showed.
 
A single dose of the vaccine candidate Ad5-nCoV, one among a handful that China is pursuing, has final-stage trials lined up in Pakistan and Russia. The candidate has been approved for use in the Chinese military.
 
Scientists outside the company have expressed concern that the effectiveness of Ad5-nCoV, which uses a common cold virus many people have contracted to carry genetic traces of the coronavirus, could be limited.
 
In response, CanSino said earlier this month there was no evidence that existing immunity against the common cold virus could severely hurt Ad5-nCoV’s ability to trigger antibodies against the new coronavirus, citing data gathered from a single dose-based Phase 2 trial.
 
In July, researchers working on Ad5-nCoV said a flexible additional dose might be able to provide enhanced immune response, based on their previous experience using this method to develop a common cold virus-based Ebola vaccine.
 
The new two-dose Phase 1 trial will test the safety of two doses and their ability to generate an immune response, showed a registration record published yesterday.
 
Researchers expect to recruit 168 healthy adults to take two doses of Ad5-nCoV for the trial estimated to begin on Sept. 20 in China’s Wuhan.
 
A CanSino representative declined to comment on the new trial. 
 
 - Reuters
 
 
Share this

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
View candlestick stock charts with Technical indicators
MQ Affiliate
Be rewarded by being an MQ Affiliate
 
 

396  550  558  646 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 LAMBO 0.0350.00 
 LUSTER 0.2250.00 
 MAHSING 1.18-0.06 
 KTB 0.155+0.04 
 LUSTER-WA 0.125-0.005 
 XOX 0.12-0.005 
 AT 0.09-0.01 
 MLAB 0.0350.00 
 DNEX 0.235+0.045 
 DNEX-WD 0.05+0.015 

FEATURED POSTS

1. The Equity Market Index Benchmark in Malaysia CMS
2. Trading Scenarios of Derivatives Bursa Derivatives Education Series
3. Derivatives 101 Bursa Derivatives Education Series
4. Why Trade FKLI? Bursa Derivatives Education Series
5. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!

TOP ARTICLES

1. DON'T FORGET TO WATCH THIS EXPLOSYF COUNTER CLOSELY !!! Bursa Master
2. IT'S A TIME FOR THIS GLOVES GOING TO SKYROCKET!!! Follow Kim's Stockwatch!
3. LUSTER - IS IT ANOTHER GLOVE TITAN? HIDDEN WINNER(S) OF PHARMACEUTICAL DEMAND PENT UP
4. SUPERMAX - BEYOND GLOVES !!! freetospeak
5. LET'S GET ROLLING THIS GLOVES TO NEXT LEVEL!!! Follow Kim's Stockwatch!
6. PublicInvest Research Daily - 19 October 2020 PublicInvest Research
7. Covid 19 cases in Malaysia - Koon Yew Yin Koon Yew Yin's Blog
8. A ZOOM Meeting With My Uncle (Retired Fund Manager) Learn from my Uncle (Retired Fund Manager)
PARTNERS & BROKERS